Platelet Rich Plasma Market Worth US$ 780.8 Million With a CAGR of 12.0% By 2027 | Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc.,

Platelet Rich Plasma Market

Overview:

Platelets contain large number of growth factors such as transforming growth factor- ß, platelet-derived growth factor, vascular endothelial growth factor, platelet-derived epidermal growth factor, fibroblastic growth factor and more. Moreover, platelets are also known to comprise cytokines along with other proteins that promote healing of a wound. Whereas platelet rich plasma is a part of the plasma fraction of blood having higher concentration of platelet, which is more than regular concentrations.

At present, the Biomedical Sealant Market is enjoying its presence over the globe. The Research report presents a complete judgment of the request which consists of unborn trends, growth factors, consumption, product volume, CAGR value, attentive opinions, profit periphery, price, and assiduity- validated request data. This report helps individualities and request challengers to prognosticate unborn profitability and to make critical opinions for business growth.

Note – This report sample includes:

• Brief Introduction to the research report.

• Table of Contents (Scope covered as a part of the study)

• Top players in the market

• Research framework (structure of the report)

• Research methodology adopted by Coherent Market Insights

To Get More Business Strategies Request Sample Copy of This Research Report:) @ https://www.coherentmarketinsights.com/insight/request-sample/1936

The global platelet-rich plasma market was valued at US$ 314.6 Mn in 2019 and is forecast to reach a value of US$ 780.8 Mn by 2027 at a CAGR of 12.0% between 2020 and 2027

Market Drivers:

Frequent product approvals and launch are expected to augment growth of the global platelet rich plasma market during the forecast period. For instance, in August 2020, the U.S. Food and Drug Administration (FDA) Office for Combination Product granted Drug/Biologic combination product designation to a chitosan-based matrix biopolymer called Ortho-R, combined with platelet-rich plasma and developed by Ortho Regenerative Technologies Inc.

Market Restraints:

Factors such as lack of proper reimbursement policies for using platelet-rich plasma treatment in cosmetic surgeries is likely to hamper growth of the global platelet rich plasma market during the forecast period.

Opportunities:

Increasing number of Research and Development activities for platelet rich plasma is anticipated to offer several growth opportunities in the global platelet rich plasma market during the forecast period. For instance, in September 2020, a team of scientists from Victoria University Australia revealed that leucocyte-rich platelet-rich plasma shows constant stimulatory anabolic as well as ergogenic effects on human fibroblast cells.

For More Information or Query or Customization before Buying, Visit at – https://www.coherentmarketinsights.com/insight/talk-to-analyst/1936

Key Takeaways:

Pure PRP segment among Types witnessed highest growth in the global platelet rich plasma market in 2019 as it accounted for 40.9% market share, owing to rise in adoption of plasma therapy.

Market Trends:

Growing number of old age population is projected to fuel growth of the global platelet rich plasma market during the forecast period. For instance, as per the data of the U.S. Census Bureau, by 2034 the number of geriatric population in the country is likely to increase to 77 million.

Furthermore, growing adoption of platelet-rich plasma is a major trend in the market, which is expected to drive growth of the global platelet rich plasma market during the forecast period. For instance, A-to-Zen Regenerative Medicine in Bellevue, expanded its skin rejuvenation treatments menu in August 2019 with PRP Facelifts and state-of-the-art PRP facials for age-defying and all-natural complexion benefits.

Key Players:

Key players functioning in the global platelet rich plasma market are Estar Technologies Ltd., Arthrex, Inc., Generex Biotechnology Corporation, Stryker Corporation, CollPlant, Johnson and Johnsons Ltd., Regen Lab S.A., Zimmer Biomet Holdings Inc., Medira Ltd., Terumo Corporation, and Glofinn Oy.

Key Developments:

January 2019: Generex Biotechnology Corporation announced the acquisition of Medisource Partners, who is FDA-registered surgical and medical product distributor for bone marrow process aspirates as well as PRP biologics during surgery.

Market Taxonomy:

• By Type:

o Pure PRP
o Leukocyte rich PRP
o Pure PRF
o Leukocyte rich PRF

• By Origin:

o Autologous
o Allogenic
o Homologues

• By Application:

o Neurosurgery
o Cosmetic Surgery
o Orthopedic Surgery
o General Surgery
o Others

• By Geography:
o North America
o Latin America
o Europe
o Middle East
o Asia Pacific
o Africa

Grab the Offer and Get UpTo 30% Discount on This Research Report 2022-2028 @ https://www.coherentmarketinsights.com/promo/buynow/1936

Table of Contents

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Type
     • Market Snippet, By Origin
     • Market Snippet, By Application
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Developments
   • Regulatory Scenario
   • PEST Analysis
   • COVID-19 Impact Analysis
4. Global Platelet Rich Plasma Market, By Type, 2016 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017–2027
     • Segment Trends
   • Pure PRP
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
   • Leukocyte rich PRP
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
   • Pure PRF
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
   • Leukocyte rich PRF
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
     • Segment Trends
5. Global Platelet Rich Plasma Market, By Origin, 2016 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017–2027
     • Segment Trends
   • Autologous
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Allogenic
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Homologues
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
6. Global Platelet Rich Plasma Market, By Application, 2016 – 2027 (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017–2027
     • Segment Trends
   • Neurosurgery
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Cosmetic Surgery
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Orthopedic Surgery
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • General Surgery
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)

View Press Release: https://www.coherentmarketinsights.com/press-release/platelet-rich-plasma-market-3492